As the economy is now in a recovery phase, investors are rotating away from stay-at-home growth stocks to relatively less expensive alternatives that are well positioned to benefit from the recovery. Abbott Laboratories (NYSE:ABT), Thermo Fisher Scientific, Inc. (NYSE:TMO), Qualcomm, Inc. (NASDAQ:QCOM), and FedEx Corporation (NYSE:FDX) possess solid growth attributes and hold the potential to perform well this quarter and beyond.Growth stocks have been investor favorites over the last decade due to their capacity to scale operations and revenues. And the past year has seen the significant dominance of technology-oriented growth stocks thanks to an increased dependence on technology amid the COVID-19 pandemic. This is evident from the SPDR Portfolio S&P 500 Growth ETF’s (SPYG) 55.9% return over this period versus the broader market SPDR S&P 500 Trust ETF’s (SPY) 49.1% gain.
As the faster-than-expected vaccination drive and government stimulus packages are driving a solid economic recovery, investors are looking for companies that will benefit from the recovery. In other words, a new set of growth stocks are emerging as the potential post-pandemic winners.
Abbott Laboratories (ABT), Thermo Fisher Scientific, Inc. (TMO), Qualcomm, Inc. (QCOM), and FedEx Corporation (FDX) are expected to witness solid growth in financials this quarter and beyond. Their quick innovation should help them stay ahead of the game in the post-pandemic world.